PSORIASIS VULGARIS PLAQUE TYPE. Psoriasis vulgaris
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Type of psoriasis vulgaris disease with mild to moderate plaque type - Not to suffer underlying diseases disrupting the therapy, such as obesity, pregnancy, dialysis, AIDS, psychotic disorder, thyroid and parathyroid T d iseases Not to use medicines affecting psoriasis disease, such as Beta-blocker, lithium, anti-malaria, corticosteroids and systemic steroids, calcium channel blockers, interleukin Confirmation of clinical diagnosis by a dermatologist
Exclusion criteria
Exclusion criteria: - Suffering each of the abovementioned diseases or confirming the diagnosis of any disease, interfering with the treatment, and mentioned in the inclusion criteria, in any moment of the treatment cycle - Patient dissatisfaction with going on the treatment Any physical and chemical trauma and surgery, which inevitably makes the patient involved, and leads to the disease exacerbation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Erythem. Timepoint: At First and End of One Month. Method of measurement: PASI QUESTIONARE.;Scaling. Timepoint: At First and End of One Month. Method of measurement: PASI QUESTIONARE.;Induration. Timepoint: At First and End of One Month. Method of measurement: PASI QUESTIONARE.;Area. Timepoint: At First and End of One Month. Method of measurement: PASI QUESTIONARE.;PASI Score. Timepoint: At First and End of One Month. Method of measurement: PASI QUESTIONARE.;QUALITY OF LIFE. Timepoint: FIRST AND ONE MONTH LATER. Method of measurement: DLQ QUESTIONNARE.;SATICFACTION. Timepoint: FIRST AND ONE MONTH LATER. Method of measurement: SATISFACTION QUESTION. | — |
Countries
Iran (Islamic Republic of)
Contacts
Iran University of Medical Sciences